These data suggest that a CD8 TRM population with an IL-17A-producing profile is constructed in the skin of psoriasis patients before disease onset in response to recruiting signals such as CCL20 and ICAM-1 and cytokines such as IL-23 and IL-15 and contributes to the appearance of psoriasis lesions in the future [20]. Here, CCL20 is linked to psoriasis.